Imagine a future where no child in Ethiopia suffers a lifetime of illness from Hepatitis B, simply because they were infected at birth. That future is now closer than ever, thanks to a groundbreaking initiative: Ethiopia has officially launched a nationwide program to administer the Hepatitis B Birth Dose (HepB BD) vaccine to newborns! This single shot, given ideally within the first 24 hours of life, could be the difference between a healthy childhood and a lifetime battling chronic disease.
This ambitious undertaking is a collaborative effort, fueled by the technical and financial support of global health giants like the World Health Organization (WHO), Gavi, the Vaccine Alliance, and UNICEF, alongside other dedicated immunization partners. But why is this vaccine so crucial, and why now?
Hepatitis B remains a significant public health threat in Ethiopia. What makes it particularly insidious is how easily it can be passed from mother to child during birth. And this is the part most people miss: if an infant contracts Hepatitis B at birth, there's a staggering 90% chance they'll develop a chronic, lifelong infection. These chronic infections can lead to severe liver damage, liver cancer, and ultimately, premature death. Think about that – a single vaccine could prevent a lifetime of suffering!
Fortunately, there's overwhelming evidence that the HepB BD vaccine is remarkably effective. Countries that have implemented similar programs have witnessed dramatic drops in childhood infection rates. The goal in Ethiopia is ambitious but achievable: to reach at least 80% of the approximately 3.8 million babies born each year.
To make this vision a reality, a comprehensive training program was rolled out across the country. In August 2025, over 100 Expanded Programme on Immunization (EPI) and Maternal and Child Health (MCH) officers participated in an intensive "Training of Trainers" workshop in Adama, supported financially by WHO. These officers then cascaded their knowledge down to the subnational levels, ensuring that healthcare workers throughout Ethiopia are well-equipped to administer the vaccine safely and effectively. This included training on timely vaccine delivery, maintaining the cold chain (keeping the vaccine at the correct temperature), accurate data reporting, and other essential aspects of newborn immunization.
But here's where it gets controversial... Some might argue that focusing on a single vaccine diverts resources from other critical healthcare needs. Is it truly the most effective use of limited funds? Others might raise concerns about vaccine hesitancy, a growing global challenge. How can Ethiopia ensure that parents embrace the HepB BD vaccine and bring their newborns in for immunization?
Extensive technical assistance has been provided by all EPI taskforces including WHO, UNICEF, Gavi, and other immunization partners. This support has been instrumental in prioritizing the HepB BD vaccine within Ethiopia’s national immunization strategy. Pilot programs in three regions helped identify potential roadblocks and refine the national rollout plan. The Ministry of Health also developed standardized training materials and successfully applied for vaccine funding from Gavi.
The recent National level Readiness Assessment Tool (RAT) score of 97% speaks volumes about Ethiopia's preparedness and dedication to the program's success.
During the launch, Dr. Dereje Duguma, State Minister of Health, emphasized the vaccine's safety and importance, stating, "What makes Hepatitis B so dangerous is that up to 90% of infants infected at birth and may develop lifelong disease. The birth-dose vaccine is key to preventing this public health challenge... This vaccine is very safe and passed all quality checks, and every parent and the community must ensure every child is reached!" He also highlighted that with the introduction of this vaccine, Ethiopia now offers 15 routine vaccines.
Dr. Kasolo, Francis Chisaka, WHO Representative to Ethiopia, echoed this sentiment, saying, "The introduction of the Hepatitis B birth dose vaccine in Ethiopia marks a critical milestone in our collective efforts to eliminate mother-to-child transmission of hepatitis B. WHO is proud to support this initiative, which will protect newborns from a preventable disease and contribute to healthier futures for Ethiopian families."
Emmanuella Baguma, the Senior Country Manager for Ethiopia at Gavi, called it a "transformative moment for child health," emphasizing that it will "help protect thousands of newborns from chronic Hepatitis B infection, especially in their most vulnerable first days of life."
Dr. Aboubacar Kampo, UNICEF Representative to Ethiopia, added, "Every child deserves a healthy start in life. Administering the Hepatitis B birth dose within the first 24 hours is one of the most effective ways to prevent chronic infection and its devastating consequences."
WHO, UNICEF, and Gavi have pledged their continued support throughout the rollout, including ongoing supervision and a post-introduction evaluation to identify areas for improvement.
This initiative represents a significant leap forward in Ethiopia's fight against Hepatitis B and its commitment to safeguarding the health of future generations. What do you think about this initiative? Will Ethiopia achieve its ambitious goal of 80% coverage? What challenges do you foresee, and how can they be overcome? Share your thoughts and opinions in the comments below!
